Viral dose, radioiodide uptake, and delayed efflux in adenovirus-mediated NIS radiovirotherapy correlates with treatment efficacy.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 567, doi. 10.1038/gt.2012.71
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2013 AND VI 20 AND IP 5
Results: 13
1
2
Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 575, doi. 10.1038/gt.2012.75
- By:
- Publication type:
- Article
3
A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 467, doi. 10.1038/gt.2012.56
- By:
- Publication type:
- Article
4
Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 497, doi. 10.1038/gt.2012.60
- By:
- Publication type:
- Article
5
RPE65 gene therapy slows cone loss in Rpe65-deficient dogs.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 545, doi. 10.1038/gt.2012.63
- By:
- Publication type:
- Article
6
Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 478, doi. 10.1038/gt.2012.57
- By:
- Publication type:
- Article
7
Lentiviral-mediated administration of IL-25 in the CNS induces alternative activation of microglia.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 487, doi. 10.1038/gt.2012.58
- By:
- Publication type:
- Article
8
Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 556, doi. 10.1038/gt.2012.73
- By:
- Publication type:
- Article
9
Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 514, doi. 10.1038/gt.2012.61
- By:
- Publication type:
- Article
10
TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 504, doi. 10.1038/gt.2012.59
- By:
- Publication type:
- Article
11
Dual-therapeutic reporter genes fusion for enhanced cancer gene therapy and imaging.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 529, doi. 10.1038/gt.2012.66
- By:
- Publication type:
- Article
12
Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 521, doi. 10.1038/gt.2012.68
- By:
- Publication type:
- Article
13
Regulation of immunological balance by sustained interferon-γ gene transfer for acute phase of atopic dermatitis in mice.
- Published in:
- Gene Therapy, 2013, v. 20, n. 5, p. 538, doi. 10.1038/gt.2012.69
- By:
- Publication type:
- Article